Phase III trial of CCNU/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT-methylated glioblastoma patients: the CeTeG/NOA-09 trial.

Herrlinger U, Tzaridis T, Mack F et al.

Neuro Oncol 2017;19 (suppl. 6) vi13 – vi 14